# Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection

> **NCT03388125** · PHASE3 · UNKNOWN · sponsor: **Sherief Abd-Elsalam** · enrollment: 113 (actual)

## Conditions studied

- Bleeding Esophageal Varices

## Interventions

- **DRUG:** Injection Sclerotherapy
- **DRUG:** N-butyl-2-cyanoacrylate

## Key facts

- **NCT ID:** NCT03388125
- **Lead sponsor:** Sherief Abd-Elsalam
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01-01
- **Primary completion:** 2017-08-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2018-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03388125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03388125, "Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03388125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*